Nuago Therapeutics, Inc. — Form D
Nuago Therapeutics, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-08. The offering totals $3.6M, of which $150K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-08
- Form: D
- Accession: 0001950101-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $150K
- Remaining: $3.5M
- Investors: 4
- Date of first sale: 2022-10-25
- Revenue range: Decline to Disclose
- SEC file number: 021-464163
Issuer
- Name: Nuago Therapeutics, Inc.
- CIK: 0001950101
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 875 NORTH MICHIGAN AVENUE, CHICAGO, IL, 60611
- Phone: 773-401-3203
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Dr. Andrea E Murmann | Director | Chicago, IL |
| Dr. Marcus E Peter | Director | Chicago, IL |
| Dr. Robert Schickel | Director | Chicago, IL |
| Dr. Andrea E Murmann | Executive Officer | Chicago, IL |
| Dr. Robert Schickel | Executive Officer | Chicago, IL |
More